Women’s Health Market Size, Share & Trends Analysis Report By Application (Postmenopausal Osteoporosis, Infertility, Endometriosis & Uterine Fibroids, Menopause, PCOS), By Age, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Women’s Health Market: Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Application
                        1.2.2. Age
                        1.2.3. Regional scope
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Women’s Health Market: Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Application outlook
                        2.2.2. Age outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Women’s Health Market: Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising incidence of target diseases
                            3.2.1.2. Increasing initiatives by government and various organizations
                            3.2.1.3. Rising publicly funded family planning services
                        3.2.2. Market restraint analysis
                            3.2.2.1. Patent expiry of major drugs
                            3.2.2.2. Lawsuits related to products
                            3.2.2.3. Adverse effects associated with use of contraceptive drugs and devices
                    3.3. Women’s Health Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                        3.3.3. Pricing Analysis
Chapter 4. Women’s Health Market: Application Estimates & Trend Analysis
                    4.1. Application Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Women’s Health Market by Application Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Hormonal infertility
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Contraceptives
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Postmenopausal osteoporosis
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Endometriosis & uterine fibroids
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.5. Menopause
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.6. Polycystic ovary syndrome (PCOS)
                            4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Women’s Health Market: Drug Estimates & Trend Analysis
                    5.1. Drug Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Women’s Health Market by Drug Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. ACTONEL
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.2. YAZ, Yasmin, Yasminelle
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.3. FORTEO
                            5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.4. Minastrin 24 Fe
                            5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.5. Mirena
                            5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.6. NuvaRing
                            5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.7. ORTHO TRI-CY LO
                            5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.8. Premarin
                            5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.9. Prolia
                            5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.10. Reclast/Aclasta
                            5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.11. XGEVA
                            5.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.12. Zometa
                            5.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.13. Others
                            5.4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Women’s Health Market: Age Estimates & Trend Analysis
                    6.1. Age Market Share, 2023 & 2030
                    6.2. Segment Dashboard
                    6.3. Global Women’s Health Market by Age Outlook
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        6.4.1. 50 years and above
                            6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.4.1.2. Postmenopausal osteoporosis
                                6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.4.1.3. Endometriosis & uterine fibroids
                                6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.4.1.4. Menopause
                                6.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            6.4.1.5. Others
                                6.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.2. Others
                            6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Women’s Health Market: Regional Estimates & Trend Analysis
                    7.1. Regional Market Share Analysis, 2023 & 2030
                    7.2. Regional Market Dashboard
                    7.3. Global Regional Market Snapshot
                    7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    7.5. North America
                        7.5.1. U.S.
                            7.5.1.1. Key country dynamics
                            7.5.1.2. Regulatory framework/ reimbursement structure
                            7.5.1.3. Competitive scenario
                            7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        7.5.2. Canada
                            7.5.2.1. Key country dynamics
                            7.5.2.2. Regulatory framework/ reimbursement structure
                            7.5.2.3. Competitive scenario
                            7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                    7.6. Europe
                        7.6.1. UK
                            7.6.1.1. Key country dynamics
                            7.6.1.2. Regulatory framework/ reimbursement structure
                            7.6.1.3. Competitive scenario
                            7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.2. Germany
                            7.6.2.1. Key country dynamics
                            7.6.2.2. Regulatory framework/ reimbursement structure
                            7.6.2.3. Competitive scenario
                            7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.3. France
                            7.6.3.1. Key country dynamics
                            7.6.3.2. Regulatory framework/ reimbursement structure
                            7.6.3.3. Competitive scenario
                            7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.4. Italy
                            7.6.4.1. Key country dynamics
                            7.6.4.2. Regulatory framework/ reimbursement structure
                            7.6.4.3. Competitive scenario
                            7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.5. Spain
                            7.6.5.1. Key country dynamics
                            7.6.5.2. Regulatory framework/ reimbursement structure
                            7.6.5.3. Competitive scenario
                            7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.6. Norway
                            7.6.6.1. Key country dynamics
                            7.6.6.2. Regulatory framework/ reimbursement structure
                            7.6.6.3. Competitive scenario
                            7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.7. Sweden
                            7.6.7.1. Key country dynamics
                            7.6.7.2. Regulatory framework/ reimbursement structure
                            7.6.7.3. Competitive scenario
                            7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        7.6.8. Denmark
                            7.6.8.1. Key country dynamics
                            7.6.8.2. Regulatory framework/ reimbursement structure
                            7.6.8.3. Competitive scenario
                            7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    7.7. Asia Pacific
                        7.7.1. Japan
                            7.7.1.1. Key country dynamics
                            7.7.1.2. Regulatory framework/ reimbursement structure
                            7.7.1.3. Competitive scenario
                            7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.2. China
                            7.7.2.1. Key country dynamics
                            7.7.2.2. Regulatory framework/ reimbursement structure
                            7.7.2.3. Competitive scenario
                            7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.3. India
                            7.7.3.1. Key country dynamics
                            7.7.3.2. Regulatory framework/ reimbursement structure
                            7.7.3.3. Competitive scenario
                            7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.4. Australia
                            7.7.4.1. Key country dynamics
                            7.7.4.2. Regulatory framework/ reimbursement structure
                            7.7.4.3. Competitive scenario
                            7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.5. South Korea
                            7.7.5.1. Key country dynamics
                            7.7.5.2. Regulatory framework/ reimbursement structure
                            7.7.5.3. Competitive scenario
                            7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        7.7.6. Thailand
                            7.7.6.1. Key country dynamics
                            7.7.6.2. Regulatory framework/ reimbursement structure
                            7.7.6.3. Competitive scenario
                            7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    7.8. Latin America
                        7.8.1. Brazil
                            7.8.1.1. Key country dynamics
                            7.8.1.2. Regulatory framework/ reimbursement structure
                            7.8.1.3. Competitive scenario
                            7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        7.8.2. Mexico
                            7.8.2.1. Key country dynamics
                            7.8.2.2. Regulatory framework/ reimbursement structure
                            7.8.2.3. Competitive scenario
                            7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                        7.8.3. Argentina
                            7.8.3.1. Key country dynamics
                            7.8.3.2. Regulatory framework/ reimbursement structure
                            7.8.3.3. Competitive scenario
                            7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    7.9. MEA
                        7.9.1. South Africa
                            7.9.1.1. Key country dynamics
                            7.9.1.2. Regulatory framework/ reimbursement structure
                            7.9.1.3. Competitive scenario
                            7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        7.9.2. Saudi Arabia
                            7.9.2.1. Key country dynamics
                            7.9.2.2. Regulatory framework/ reimbursement structure
                            7.9.2.3. Competitive scenario
                            7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        7.9.3. UAE
                            7.9.3.1. Key country dynamics
                            7.9.3.2. Regulatory framework/ reimbursement structure
                            7.9.3.3. Competitive scenario
                            7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        7.9.4. Kuwait
                            7.9.4.1. Key country dynamics
                            7.9.4.2. Regulatory framework/ reimbursement structure
                            7.9.4.3. Competitive scenario
                            7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Recent Developments & Impact Analysis, By Key Market Participants
                    8.2. Company/Competition Categorization
                    8.3. Vendor Landscape
                        8.3.1. List of key distributors and channel partners
                        8.3.2. Key customers
                        8.3.3. Key company market share analysis, 2023
                        8.3.4. AbbVie, Inc.
                            8.3.4.1. Company overview
                            8.3.4.2. Financial performance
                            8.3.4.3. Product benchmarking
                            8.3.4.4. Strategic initiatives
                        8.3.5. Bayer AG
                            8.3.5.1. Company overview
                            8.3.5.2. Financial performance
                            8.3.5.3. Product benchmarking
                            8.3.5.4. Strategic initiatives
                        8.3.6. Merck & Co., Inc.
                            8.3.6.1. Company overview
                            8.3.6.2. Financial performance
                            8.3.6.3. Product benchmarking
                            8.3.6.4. Strategic initiatives
                        8.3.7. Pfizer, Inc.
                            8.3.7.1. Company overview
                            8.3.7.2. Financial performance
                            8.3.7.3. Product benchmarking
                            8.3.7.4. Strategic initiatives
                        8.3.8. Teva Pharmaceutical Industries Ltd.
                            8.3.8.1. Company overview
                            8.3.8.2. Financial performance
                            8.3.8.3. Product benchmarking
                            8.3.8.4. Strategic initiatives
                        8.3.9. Agile Therapeutics
                            8.3.9.1. Company overview
                            8.3.9.2. Financial performance
                            8.3.9.3. Product benchmarking
                            8.3.9.4. Strategic initiatives
                        8.3.10. Amgen, Inc.
                            8.3.10.1. Company overview
                            8.3.10.2. Financial performance
                            8.3.10.3. Product benchmarking
                            8.3.10.4. Strategic initiatives
                        8.3.11. Apothecary Pharmaceutical Corp.
                            8.3.11.1. Company overview
                            8.3.11.2. Financial performance
                            8.3.11.3. Product benchmarking
                            8.3.11.4. Strategic initiatives
                        8.3.12. Blairex Laboratories, Inc.
                            8.3.12.1. Company overview
                            8.3.12.2. Financial performance
                            8.3.12.3. Product benchmarking
                            8.3.12.4. Strategic initiatives
                        8.3.13. Ferring B.V.
                            8.3.13.1. Company overview
                            8.3.13.2. Financial performance
                            8.3.13.3. Product benchmarking
                            8.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America women’s health market, by region, 2018 - 2030 (USD Million)
Table 3 North America women’s health market, by application, 2018 - 2030 (USD Million)
Table 4 North America women’s health market, by drug, 2018 - 2030 (USD Million)
Table 5 North America women’s health market, by age, 2018 - 2030 (USD Million)
Table 6 U.S. women’s health market, by application, 2018 - 2030 (USD Million)
Table 7 U.S. women’s health market, by drug, 2018 - 2030 (USD Million)
Table 8 U.S. women’s health market, by age, 2018 - 2030 (USD Million)
Table 9 Canada women’s health market, by application, 2018 - 2030 (USD Million)
Table 10 Canada women’s health market, by drug, 2018 - 2030 (USD Million)
Table 11 Canada women’s health market, by age, 2018 - 2030 (USD Million)
Table 12 Europe women’s health market, by region, 2018 - 2030 (USD Million)
Table 13 Europe women’s health market, by application, 2018 - 2030 (USD Million)
Table 14 Europe women’s health market, by drug, 2018 - 2030 (USD Million)
Table 15 Europe women’s health market, by age, 2018 - 2030 (USD Million)
Table 16 Germany women’s health market, by application, 2018 - 2030 (USD Million)
Table 17 Germany women’s health market, by drug, 2018 - 2030 (USD Million)
Table 18 Germany women’s health market, by age, 2018 - 2030 (USD Million)
Table 19 UK women’s health market, by application, 2018 - 2030 (USD Million)
Table 20 UK women’s health market, by drug, 2018 - 2030 (USD Million)
Table 21 UK women’s health market, by age, 2018 - 2030 (USD Million)
Table 22 France women’s health market, by application, 2018 - 2030 (USD Million)
Table 23 France women’s health market, by drug, 2018 - 2030 (USD Million)
Table 24 France women’s health market, by age, 2018 - 2030 (USD Million)
Table 25 Italy women’s health market, by application, 2018 - 2030 (USD Million)
Table 26 Italy women’s health market, by drug, 2018 - 2030 (USD Million)
Table 27 Italy women’s health market, by age, 2018 - 2030 (USD Million)
Table 28 Spain women’s health market, by application, 2018 - 2030 (USD Million)
Table 29 Spain women’s health market, by drug, 2018 - 2030 (USD Million)
Table 30 Spain women’s health market, by age, 2018 - 2030 (USD Million)
Table 31 Denmark women’s health market, by application, 2018 - 2030 (USD Million)
Table 32 Denmark women’s health market, by drug, 2018 - 2030 (USD Million)
Table 33 Denmark women’s health market, by age, 2018 - 2030 (USD Million)
Table 34 Sweden women’s health market, by application, 2018 - 2030 (USD Million)
Table 35 Sweden women’s health market, by drug, 2018 - 2030 (USD Million)
Table 36 Sweden women’s health market, by age, 2018 - 2030 (USD Million)
Table 37 Norway women’s health market, by application, 2018 - 2030 (USD Million)
Table 38 Norway women’s health market, by drug, 2018 - 2030 (USD Million)
Table 39 Norway women’s health market, by age, 2018 - 2030 (USD Million)
Table 40 Asia Pacific women’s health market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific women’s health market, by application, 2018 - 2030 (USD Million)
Table 42 Asia Pacific women’s health market, by drug, 2018 - 2030 (USD Million)
Table 43 Asia Pacific women’s health market, by age, 2018 - 2030 (USD Million)
Table 44 China women’s health market, by application, 2018 - 2030 (USD Million)
Table 45 China women’s health market, by drug, 2018 - 2030 (USD Million)
Table 46 China women’s health market, by age, 2018 - 2030 (USD Million)
Table 47 Japan women’s health market, by application, 2018 - 2030 (USD Million)
Table 48 Japan women’s health market, by drug, 2018 - 2030 (USD Million)
Table 49 Japan women’s health market, by age, 2018 - 2030 (USD Million)
Table 50 India women’s health market, by application, 2018 - 2030 (USD Million)
Table 51 India women’s health market, by drug, 2018 - 2030 (USD Million)
Table 52 India women’s health market, by age, 2018 - 2030 (USD Million)
Table 53 South Korea women’s health market, by application, 2018 - 2030 (USD Million)
Table 54 South Korea women’s health market, by drug, 2018 - 2030 (USD Million)
Table 55 South Korea women’s health market, by age, 2018 - 2030 (USD Million)
Table 56 Australia women’s health market, by application, 2018 - 2030 (USD Million)
Table 57 Australia women’s health market, by drug, 2018 - 2030 (USD Million)
Table 58 Australia women’s health market, by age, 2018 - 2030 (USD Million)
Table 59 Thailand women’s health market, by application, 2018 - 2030 (USD Million)
Table 60 Thailand women’s health market, by drug, 2018 - 2030 (USD Million)
Table 61 Thailand women’s health market, by age, 2018 - 2030 (USD Million)
Table 62 Latin America women’s health market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America women’s health market, by age, 2018 - 2030 (USD Million)
Table 64 Latin America women’s health market, by drug, 2018 - 2030 (USD Million)
Table 65 Latin America women’s health market, by application, 2018 - 2030 (USD Million)
Table 66 Brazil women’s health market, by application, 2018 - 2030 (USD Million)
Table 67 Brazil women’s health market, by drug, 2018 - 2030 (USD Million)
Table 68 Brazil women’s health market, by age, 2018 - 2030 (USD Million)
Table 69 Mexico women’s health market, by application, 2018 - 2030 (USD Million)
Table 70 Mexico women’s health market, by drug, 2018 - 2030 (USD Million)
Table 71 Mexico women’s health market, by age, 2018 - 2030 (USD Million)
Table 72 Argentina women’s health market, by application, 2018 - 2030 (USD Million)
Table 73 Argentina women’s health market, by drug, 2018 - 2030 (USD Million)
Table 74 Argentina women’s health market, by age, 2018 - 2030 (USD Million)
Table 75 MEA women’s health market, by region, 2018 - 2030 (USD Million)
Table 76 MEA women’s health market, by application, 2018 - 2030 (USD Million)
Table 77 MEA women’s health market, by drug, 2018 - 2030 (USD Million)
Table 78 MEA women’s health market, by age, 2018 - 2030 (USD Million)
Table 79 South Africa women’s health market, by application, 2018 - 2030 (USD Million)
Table 80 South Africa women’s health market, by drug, 2018 - 2030 (USD Million)
Table 81 South Africa women’s health market, by age, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia women’s health market, by application, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia women’s health market, by drug, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia women’s health market, by age, 2018 - 2030 (USD Million)
Table 85 UAE women’s health market, by application, 2018 - 2030 (USD Million)
Table 86 UAE women’s health market, by drug, 2018 - 2030 (USD Million)
Table 87 UAE women’s health market, by age, 2018 - 2030 (USD Million)
Table 88 Kuwait women’s health market, by application, 2018 - 2030 (USD Million)
Table 89 Kuwait women’s health market, by drug, 2018 - 2030 (USD Million)
Table 90 Kuwait women’s health market, by age, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Women’s health market: market outlook
Fig. 14 Women’s health competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Women’s health market driver impact
Fig. 20 Women’s health market restraint impact
Fig. 21 Women’s health market strategic initiatives analysis
Fig. 22 Women’s health market: Application movement analysis
Fig. 23 Women’s health market: Application outlook and key takeaways
Fig. 24 Hormonal infertility market estimates and forecast, 2018 - 2030
Fig. 25 Contraceptives estimates and forecast, 2018 - 2030
Fig. 26 Postmenopausal osteoporosis market estimates and forecast, 2018 - 2030
Fig. 27 Endometriosis & uterine fibroids estimates and forecast, 2018 - 2030
Fig. 28 Menopause market estimates and forecast, 2018 - 2030
Fig. 29 Polycystic ovary syndrome (PCOS) estimates and forecast, 2018 - 2030
Fig. 30 Women’s health market: Drug movement analysis
Fig. 31 Women’s health market: Drug outlook and key takeaways
Fig. 32 ACTONEL market estimates and forecast, 2018 - 2030
Fig. 33 YAZ, Yasmin, Yasminelle estimates and forecast, 2018 - 2030
Fig. 34 FORTEO market estimates and forecast, 2018 - 2030
Fig. 35 Minastrin 24 Fe estimates and forecast, 2018 - 2030
Fig. 36 Mirena market estimates and forecast, 2018 - 2030
Fig. 37 NuvaRing estimates and forecast, 2018 - 2030
Fig. 38 ORTHO TRI-CY LO market estimates and forecast, 2018 - 2030
Fig. 39 Premarin estimates and forecast, 2018 - 2030
Fig. 40 Prolia market estimates and forecast, 2018 - 2030
Fig. 41 Reclast/Aclasta estimates and forecast, 2018 - 2030
Fig. 42 XGEVA market estimates and forecast, 2018 - 2030
Fig. 43 Zometa estimates and forecast, 2018 - 2030
Fig. 44 Others estimates and forecast, 2018 - 2030
Fig. 45 Women’s health Market: Age movement Analysis
Fig. 46 Women’s health market: Age outlook and key takeaways
Fig. 47 50 years and above market estimates and forecasts, 2018 - 2030
Fig. 48 Postmenopausal osteoporosis market estimates and forecasts,2018 - 2030
Fig. 49 Endometriosis & uterine fibroids market estimates and forecasts,2018 - 2030
Fig. 50 Menopause market estimates and forecasts,2018 - 2030
Fig. 51 Others market estimates and forecasts,2018 - 2030
Fig. 52 Others market estimates and forecasts,2018 - 2030
Fig. 53 Global women’s health market: Regional movement analysis
Fig. 54 Global women’s health market: Regional outlook and key takeaways
Fig. 55 Global women’s health market share and leading players
Fig. 56 North America market share and leading players
Fig. 57 Europe market share and leading players
Fig. 58 Asia Pacific market share and leading players
Fig. 59 Latin America market share and leading players
Fig. 60 Middle East & Africa market share and leading players
Fig. 61 North America: SWOT
Fig. 62 Europe SWOT
Fig. 63 Asia Pacific SWOT
Fig. 64 Latin America SWOT
Fig. 65 MEA SWOT
Fig. 66 North America, by country
Fig. 67 North America
Fig. 68 North America market estimates and forecasts, 2018 - 2030
Fig. 69 U.S.
Fig. 70 U.S. market estimates and forecasts, 2018 - 2030
Fig. 71 Canada
Fig. 72 Canada market estimates and forecasts, 2018 - 2030
Fig. 73 Europe
Fig. 74 Europe market estimates and forecasts, 2018 - 2030
Fig. 75 UK
Fig. 76 UK market estimates and forecasts, 2018 - 2030
Fig. 77 Germany
Fig. 78 Germany market estimates and forecasts, 2018 - 2030
Fig. 79 France
Fig. 80 France market estimates and forecasts, 2018 - 2030
Fig. 81 Italy
Fig. 82 Italy market estimates and forecasts, 2018 - 2030
Fig. 83 Spain
Fig. 84 Spain market estimates and forecasts, 2018 - 2030
Fig. 85 Denmark
Fig. 86 Denmark market estimates and forecasts, 2018 - 2030
Fig. 87 Sweden
Fig. 88 Sweden market estimates and forecasts, 2018 - 2030
Fig. 89 Norway
Fig. 90 Norway market estimates and forecasts, 2018 - 2030
Fig. 91 Asia Pacific
Fig. 92 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 93 China
Fig. 94 China market estimates and forecasts, 2018 - 2030
Fig. 95 Japan
Fig. 96 Japan market estimates and forecasts, 2018 - 2030
Fig. 97 India
Fig. 98 India market estimates and forecasts, 2018 - 2030
Fig. 99 Thailand
Fig. 100 Thailand market estimates and forecasts, 2018 - 2030
Fig. 101 South Korea
Fig. 102 South Korea market estimates and forecasts, 2018 - 2030
Fig. 103 Australia
Fig. 104 Australia market estimates and forecasts, 2018 - 2030
Fig. 105 Latin America
Fig. 106 Latin America market estimates and forecasts, 2018 - 2030
Fig. 107 Brazil
Fig. 108 Brazil market estimates and forecasts, 2018 - 2030
Fig. 109 Mexico
Fig. 110 Mexico market estimates and forecasts, 2018 - 2030
Fig. 111 Argentina
Fig. 112 Argentina market estimates and forecasts, 2018 - 2030
Fig. 113 Middle East and Africa
Fig. 114 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 115 South Africa
Fig. 116 South Africa market estimates and forecasts, 2018 - 2030
Fig. 117 Saudi Arabia
Fig. 118 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 119 UAE
Fig. 120 UAE market estimates and forecasts, 2018 - 2030
Fig. 121 Kuwait
Fig. 122 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 123 Market share of key market players- Women’s health market